KUALA LUMPUR, April 14 (Bernama) -- CUKTECH, a global leader in intelligent power solutions, has announced the official Malaysian launch of its flagship CUKTECH 15 Charging Station, featuring smart capabilities and high-efficiency performance.
Positioned as the ultimate "Desktop Power Hub", the device is designed to address common user pain points such as cable clutter and fast-charging incompatibility while redefining the minimalist digital workspace, according to a statement.
Built on a "6-in-1" concept, the CUKTECH 15 can power up to six devices simultaneously. Its configuration includes dual Type-C ports, a USB-A port, dual wireless charging zones, and an integrated retractable cable system supporting 120 watts (W) MAX fast charging.
For Malaysian professionals managing home offices, mobile work, or multi-device setups, the high-power multi-port design reduces desktop clutter and eliminates the need for multiple adapters.
The front of the charging station features a 1.83-inch TFT display, providing real-time visualisation of total power, individual port output status, and charging protocols. This "Visual Charging" function supports efficient device management, making it suitable for creative studios, shared workspaces, and modern households.
The device also supports PD 3.1, Xiaomi 120W, and ADC 2.0 fast-charging protocols, enabling compatibility with a wide range of Android smartphones, tablets, and ultrabooks across different brands.
Engineered for tropical climates, the CUKTECH 15 is equipped with the proprietary Cool+ cooling system, ensuring stable operation under full load while enhancing battery protection and charging safety.
The CUKTECH 15 Charging Station is now available across major e-commerce platforms in Malaysia, including CUKTECH official stores on Shopee and Lazada.
-- BERNAMA
Tuesday, 14 April 2026
Saturday, 11 April 2026
iFLYTEK Unveils Virtual Human Solutions At Singapore Event
KUALA LUMPUR, April 10 (Bernama) -- iFLYTEK, a global leader in intelligent speech and AI technologies, has unveiled its lineup of virtual human technologies at the GITEX ASIA 2026 in Singapore, drawing strong interest from visitors across the exhibition floor.
Powered by its integrated artificial intelligence (AI) infrastructure, the virtual humans are capable of perceiving, interacting, and delivering services in real-world environments.
“Our virtual human technologies are built to integrate into real service scenarios across industries. They help organisations deliver efficient services while making human-AI interaction more natural and accessible in everyday work and life,” said its Vice President, Vincent Zhan.
At the two-day event, iFLYTEK in a statement highlighted GuideX, its intelligent virtual human solution designed for public service environments, capable of managing the full passenger service flow in airport settings, from greeting and answering queries to check-in assistance and gate guidance.
By integrating multiple functions into a single interface, the system supports multimodal interaction, including voice, touch, and visual recognition, helping to streamline passenger journeys and improve operational efficiency.
Visual recognition includes lip movement and gesture recognition, while voice recognition features noise reduction for clearer communication. The system understands spoken queries, responds naturally, and functions as an intelligent service hub rather than a basic talking avatar.
GuideX operates as a round-the-clock service assistant in busy public environments and is also designed for use in transport hubs, hotels, retail stores, shopping malls, and exhibition venues.
-- BERNAMA
Friday, 10 April 2026
ICHAM LAUNCHES OPEN-ENDED VCC FUND FOCUSES ON AUTOCALL STRUCTURED PRODUCTS
KUALA LUMPUR, April 10 (Bernama) -- ICHAM Pte Ltd (ICHAM), a regional multi-family office and asset manager, has launched a new open-ended Singapore Variable Capital Company (VCC) fund focused on autocall structured products, available exclusively to accredited and institutional investors.
In a statement, ICHAM said the fund offers access to a professionally managed portfolio of structured products in a fund format, providing a simplified, institutional approach while complementing diversified equity portfolios with equity-like return characteristics and a focus on lower volatility.
ICHAM Chief Executive Officer, Archan Chamapun said the fund provides accredited and institutional investors with access to a professionally managed portfolio of autocall structured products, which have traditionally been distributed by private banks as individual investments that may involve concentrated exposures and less transparent fee structures.
Meanwhile, lead Portfolio Manager of the fund, Felix Chew said the strategy is designed to complement diversified portfolios by providing access to structured product investments through a professionally managed approach.
The fund adopts an institutional approach with a focus on risk management, ongoing oversight, and a transparent, investor-aligned fee structure, aiming to complement broader investment portfolios through a diversified pool of such investments.
ICHAM is recognised for its expertise in alternative asset classes and structured products, having served accredited and institutional investors with tailored investment solutions since 2019, supported by a team with extensive experience in Asian financial markets.
The firm is regulated by the Monetary Authority of Singapore and focuses on delivering institutional-grade investment solutions with transparent fee structures and disciplined risk management.
-- BERNAMA
In a statement, ICHAM said the fund offers access to a professionally managed portfolio of structured products in a fund format, providing a simplified, institutional approach while complementing diversified equity portfolios with equity-like return characteristics and a focus on lower volatility.
ICHAM Chief Executive Officer, Archan Chamapun said the fund provides accredited and institutional investors with access to a professionally managed portfolio of autocall structured products, which have traditionally been distributed by private banks as individual investments that may involve concentrated exposures and less transparent fee structures.
Meanwhile, lead Portfolio Manager of the fund, Felix Chew said the strategy is designed to complement diversified portfolios by providing access to structured product investments through a professionally managed approach.
The fund adopts an institutional approach with a focus on risk management, ongoing oversight, and a transparent, investor-aligned fee structure, aiming to complement broader investment portfolios through a diversified pool of such investments.
ICHAM is recognised for its expertise in alternative asset classes and structured products, having served accredited and institutional investors with tailored investment solutions since 2019, supported by a team with extensive experience in Asian financial markets.
The firm is regulated by the Monetary Authority of Singapore and focuses on delivering institutional-grade investment solutions with transparent fee structures and disciplined risk management.
-- BERNAMA
IFLYTEK SHOWCASES AI TRANSLATION DEVICES AT GITEX ASIA 2026
KUALA LUMPUR, April 10 (Bernama) -- iFLYTEK showcased its latest artificial intelligence (AI) translation devices, including AI Glasses and the AI Interpret Mic, at GITEX ASIA 2026, highlighting its expanding portfolio of AI-powered communication solutions.
In a statement, the company said it demonstrated how its large-model AI technology enables accurate, secure and scalable multilingual interactions across business and everyday scenarios.
“Clear communication is the cornerstone of global collaboration. With our AI translation technologies, we are helping people and businesses connect with greater clarity and confidence worldwide,” said iFLYTEK Vice President, Vincent Zhan.
The new AI Glasses support real-time face-to-face translation with a first-of-its-kind multimodal noise reduction with lip-reading recognition, while the AI Interpret Mic is designed for professional conferences, offering simultaneous interpretation integrated with event systems.
Beyond these devices, iFLYTEK presented a broader ecosystem of AI translation tools spanning office productivity, travel and large-scale events. These include AI-powered transcription solutions, translation earbuds, smart translators and enterprise-level interpretation systems, all aimed at enabling seamless cross-language communication.
The portfolio reflects iFLYTEK’s strategy to build a full-scenario AI translation framework, leveraging its long-standing expertise in speech and language technologies to support global collaboration.
The solutions are being showcased at GITEX ASIA 2026, where iFLYTEK is also presenting its broader AI infrastructure and enterprise applications.
-- BERNAMA
In a statement, the company said it demonstrated how its large-model AI technology enables accurate, secure and scalable multilingual interactions across business and everyday scenarios.
“Clear communication is the cornerstone of global collaboration. With our AI translation technologies, we are helping people and businesses connect with greater clarity and confidence worldwide,” said iFLYTEK Vice President, Vincent Zhan.
The new AI Glasses support real-time face-to-face translation with a first-of-its-kind multimodal noise reduction with lip-reading recognition, while the AI Interpret Mic is designed for professional conferences, offering simultaneous interpretation integrated with event systems.
Beyond these devices, iFLYTEK presented a broader ecosystem of AI translation tools spanning office productivity, travel and large-scale events. These include AI-powered transcription solutions, translation earbuds, smart translators and enterprise-level interpretation systems, all aimed at enabling seamless cross-language communication.
The portfolio reflects iFLYTEK’s strategy to build a full-scenario AI translation framework, leveraging its long-standing expertise in speech and language technologies to support global collaboration.
The solutions are being showcased at GITEX ASIA 2026, where iFLYTEK is also presenting its broader AI infrastructure and enterprise applications.
-- BERNAMA
IFLYTEK UNVEILS WORLD’S THINNEST AI E-INK TABLET FOR PROFESSIONAL PRODUCTIVITY
KUALA LUMPUR, April 10 (Bernama) -- iFLYTEK, a global leader in intelligent speech and artificial intelligence (AI) technologies, unveiled AINOTE 2, the world’s thinnest AI-powered e-ink tablet, at GITEX ASIA 2026 in Singapore.
At the two-day event beginning April 9, the company highlighted AINOTE 2 as a tool to enhance professional productivity through focused thinking, secure communication, and smarter workflows.
More than a digital notebook, AINOTE 2 combines a paper-like writing experience with an ultra-thin design certified by Guinness World Records, delivering a distraction-free workspace that helps professionals stay focused and work efficiently in demanding environments.
According to iFLYTEK in a statement, the device, weighing 295 grammes and measuring 4.2 millimetres thick, is designed for portability while offering a 10.65-inch e-ink workspace for focused reading and note-taking.
AINOTE 2 addresses common challenges in professional settings, where constant note-taking can lead to missed details and time-consuming follow-ups. It features one-click recording and real-time transcription in 16 languages, automatically capturing conversations so users can stay fully engaged.
Real-time translation in 11 languages, along with speaker identification, further supports seamless cross-border collaboration.
Its paper-like display with low handwriting latency enables natural, responsive writing, allowing users to jot down ideas or sketch thoughts without disrupting the flow of discussion. Handwritten notes can also be converted into searchable text in 133 languages, ensuring insights are preserved and easy to retrieve.
In addition, AINOTE 2 supports offline transcription, allowing sensitive conversations to be recorded and processed without an internet connection, reinforcing trust in privacy-sensitive environments.
-- BERNAMA
At the two-day event beginning April 9, the company highlighted AINOTE 2 as a tool to enhance professional productivity through focused thinking, secure communication, and smarter workflows.
More than a digital notebook, AINOTE 2 combines a paper-like writing experience with an ultra-thin design certified by Guinness World Records, delivering a distraction-free workspace that helps professionals stay focused and work efficiently in demanding environments.
According to iFLYTEK in a statement, the device, weighing 295 grammes and measuring 4.2 millimetres thick, is designed for portability while offering a 10.65-inch e-ink workspace for focused reading and note-taking.
AINOTE 2 addresses common challenges in professional settings, where constant note-taking can lead to missed details and time-consuming follow-ups. It features one-click recording and real-time transcription in 16 languages, automatically capturing conversations so users can stay fully engaged.
Real-time translation in 11 languages, along with speaker identification, further supports seamless cross-border collaboration.
Its paper-like display with low handwriting latency enables natural, responsive writing, allowing users to jot down ideas or sketch thoughts without disrupting the flow of discussion. Handwritten notes can also be converted into searchable text in 133 languages, ensuring insights are preserved and easy to retrieve.
In addition, AINOTE 2 supports offline transcription, allowing sensitive conversations to be recorded and processed without an internet connection, reinforcing trust in privacy-sensitive environments.
-- BERNAMA
Thursday, 9 April 2026
REGASK PARTNERS VEEVA TO BRING AI-DRIVEN REGULATORY INTELLIGENCE TO RIM
KUALA LUMPUR, April 9 (Bernama) -- RegASK has partnered with Veeva Systems to integrate its agentic artificial intelligence (AI) capabilities with Veeva’s Regulatory Information Management (RIM) system, enabling life sciences organisations to connect near-real-time regulatory insights with core compliance workflows.
Through the collaboration, organisations can translate regulatory changes into structured assessments, prioritised actions and documented compliance decisions within existing systems of record.
According to a statement, the integration combines Veeva’s unified regulatory platform with RegASK’s AI-driven intelligence layer to enhance decision-making and operational efficiency.
“Through our partnership with Veeva, joint customers gain RegASK’s intelligence and predictive layer to help stay ahead of regulatory change.
“Through our integration with Veeva RIM, teams can connect that intelligence directly to their compliance workflows, enabling faster and more confident regulatory decisions,” said RegASK Founder and Chief Executive Officer, Caroline Shleifer.
RegASK’s platform continuously monitors regulatory developments across more than 160 markets, leveraging large language models and a global network of subject matter experts to convert updates into actionable compliance steps.
The solution is built to enterprise-grade security standards, with multiple certifications, including ISO/IEC 42001 for AI management systems.
The partnership reflects a broader shift in the life sciences sector, where regulatory intelligence is becoming a strategic capability. By embedding AI-driven insights into compliance systems, RegASK and Veeva aim to help organisations respond more proactively to global regulatory changes and accelerate time to market.
-- BERNAMA
Through the collaboration, organisations can translate regulatory changes into structured assessments, prioritised actions and documented compliance decisions within existing systems of record.
According to a statement, the integration combines Veeva’s unified regulatory platform with RegASK’s AI-driven intelligence layer to enhance decision-making and operational efficiency.
“Through our partnership with Veeva, joint customers gain RegASK’s intelligence and predictive layer to help stay ahead of regulatory change.
“Through our integration with Veeva RIM, teams can connect that intelligence directly to their compliance workflows, enabling faster and more confident regulatory decisions,” said RegASK Founder and Chief Executive Officer, Caroline Shleifer.
RegASK’s platform continuously monitors regulatory developments across more than 160 markets, leveraging large language models and a global network of subject matter experts to convert updates into actionable compliance steps.
The solution is built to enterprise-grade security standards, with multiple certifications, including ISO/IEC 42001 for AI management systems.
The partnership reflects a broader shift in the life sciences sector, where regulatory intelligence is becoming a strategic capability. By embedding AI-driven insights into compliance systems, RegASK and Veeva aim to help organisations respond more proactively to global regulatory changes and accelerate time to market.
-- BERNAMA
Wednesday, 8 April 2026
MEIJI PHARMA ASIA BEGINS OPERATIONS IN SINGAPORE TO STRENGTHEN ASEAN PRESENCE
KUALA LUMPUR, April 8 (Bernama) -- Meiji Seika Pharma Co Ltd has announced that its subsidiary, Meiji Pharma Asia Pte Ltd, commenced operations in Singapore on April 1, marking a strategic move to strengthen its presence in the ASEAN region.
In a statement, the company said the Singapore-based subsidiary will support the commercialisation, marketing and distribution of pharmaceuticals, including vaccines, across the region.
Meiji Seika Pharma aims to become “a leading company in Asia in the field of infectious diseases” under its “Meiji Group 2026 Vision”, leveraging nearly half a century of experience in manufacturing and marketing pharmaceuticals in Thailand and Indonesia.
Singapore will serve as a regional hub for the company’s business and commercial strategies, aimed at enhancing its influence and accelerating growth across ASEAN markets.
Established on Dec 10, 2025, Meiji Pharma Asia will focus on pharmaceuticals for infectious diseases, haematologic cancers and lifestyle-related diseases, with the aim of ensuring reliable supply and contributing to public health in the region.
-- BERNAMA
In a statement, the company said the Singapore-based subsidiary will support the commercialisation, marketing and distribution of pharmaceuticals, including vaccines, across the region.
Meiji Seika Pharma aims to become “a leading company in Asia in the field of infectious diseases” under its “Meiji Group 2026 Vision”, leveraging nearly half a century of experience in manufacturing and marketing pharmaceuticals in Thailand and Indonesia.
Singapore will serve as a regional hub for the company’s business and commercial strategies, aimed at enhancing its influence and accelerating growth across ASEAN markets.
Established on Dec 10, 2025, Meiji Pharma Asia will focus on pharmaceuticals for infectious diseases, haematologic cancers and lifestyle-related diseases, with the aim of ensuring reliable supply and contributing to public health in the region.
-- BERNAMA
Subscribe to:
Posts (Atom)